Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Yu-Xian Teng"'
Autor:
Da-Long Yang, Shao-Ping Liu, Hong-Liang Wang, Jian-Rong Li, Jia-Yong Su, Min-Jun Li, Yu-Xian Teng, Zhu-Jian Deng, Zhong-Hai Li, Jian-Li Huang, Ping-Ping Guo, Liang Ma, Zhen-Zhen Li, Jian-Hong Zhong
Publikováno v:
Infectious Agents and Cancer, Vol 19, Iss 1, Pp 1-11 (2024)
Abstract Aims This study compared the prevalences of metabolic syndrome and of cardiac or kidney comorbidities among patients with hepatocellular carcinoma (HCC) associated with metabolic dysfunction-related fatty liver disease (MAFLD), chronic infec
Externí odkaz:
https://doaj.org/article/b7b660a8a07043b0bd64193a66e265b8
Autor:
Lei Liu, Si Xie, Yu-Xian Teng, Zhu-Jian Deng, Kang Chen, Hao-Tian Liu, Rong-Rui Huo, Xiu-Mei Liang, Ping-Ping Guo, Da-Long Yang, Liang Ma, Bang-De Xiang, Le-Qun Li, Jian-Hong Zhong
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
AimsThis study aims to determine differences in severity of background liver disease at hepatocellular carcinoma (HCC) diagnosis and long-term survival outcomes among patients undergoing liver resection for HCC in the background of metabolic dysfunct
Externí odkaz:
https://doaj.org/article/dd2f4f63ab9a436aaf58ac1edde8a490
Publikováno v:
In Applied Catalysis B: Environment and Energy 5 September 2024 352
Publikováno v:
Expert Review of Gastroenterology & Hepatology. 17:499-507
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f561b4b4de62382be4e99b211a38c1f0
https://doi.org/10.1080/17474124.2023.2196403
https://doi.org/10.1080/17474124.2023.2196403
Autor:
Yu‐Xian Teng, Wan‐Guang Zhang, Anthony Wing‐hung Chan, Charing Ching Ning Chong, Matteo Serenari, Yan‐Yan Wang, Ning Peng, Tao Huang, Shi‐Dong Lu, Zhi‐Yin Liang, Liang Ma, Jian‐Hong Zhong
Publikováno v:
Alimentary Pharmacology & Therapeutics. 57:810-812
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d659dbc43afe32471268378d52366706
https://doi.org/10.1111/apt.17409
https://doi.org/10.1111/apt.17409
Autor:
Le Li, Hao-Tian Liu, Yu-Xian Teng, Zhu-Jian Deng, Guan-Lan Zhang, Jia-Yong Su, Liang Ma, Jian-Hong Zhong
Publikováno v:
Expert Opinion on Investigational Drugs. 31:1151-1167
Since the approval of sorafenib for systemic treatment of advanced hepatocellular carcinoma (HCC), many tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) have shown efficacy and tolerability as first-line treatments. On the ot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6f2d37a8616e7f522085e5c07aae313
https://doi.org/10.1080/13543784.2022.2151891
https://doi.org/10.1080/13543784.2022.2151891
Autor:
Hao-Tian Liu, Cheng-Piao Luo, Meng-Jie Jiang, Zhu-Jian Deng, Yu-Xian Teng, Jia-Yong Su, Li-Xin Pan, Liang Ma, Ping-Ping Guo, Jian-Hong Zhong
Publikováno v:
Clinical and Translational Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64768dffa53aefedba98ddb2cd2f73bf
https://doi.org/10.1007/s12094-023-03164-y
https://doi.org/10.1007/s12094-023-03164-y
Autor:
Jia-Yong Su, Zhu-Jian Deng, Yu-Xian Teng, Ye Xin Koh, Wan-Guang Zhang, Ming-Hua Zheng, Si Xie, Rong-Rui Huo, Chao-Jing Chen, Liang Ma, Jian-Hong Zhong
Publikováno v:
BJS Open. 7
Background Whether the safety and efficacy of hepatic resection differ between patients whose hepatocellular carcinoma (HCC) is related to non-alcoholic fatty liver disease (NAFLD) or has other aetiologies is unknown. A systematic review was performe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a701fd27a6fbed587b6f632b97c67786
https://doi.org/10.1093/bjsopen/zrac167
https://doi.org/10.1093/bjsopen/zrac167
Autor:
yu-xian teng
Publikováno v:
Eurasian Journal of Medicine and Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03bd1384cd9c19ca09bbe6c9e59a9551
https://doi.org/10.14744/ejmo.2022.25618
https://doi.org/10.14744/ejmo.2022.25618
Autor:
Yu-Xian Teng, Si Xie, Ping-Ping Guo, Zhu-Jian Deng, Zi-Yi Zhang, Wei Gao, Wan-Guang Zhang, Jian-Hong Zhong
Publikováno v:
Journal of clinical and translational hepatology. 10(5)
The rising global prevalence of metabolic diseases has increased the prevalence of non-alcoholic fatty liver disease (NAFLD), leading to an increase in cases of NAFLD-related hepatocellular carcinoma (HCC). To provide an updated literature review det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::331d445fdd0a2009bb524ad97aafef50
https://pubmed.ncbi.nlm.nih.gov/36304509
https://pubmed.ncbi.nlm.nih.gov/36304509